Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × siltuximab × Clear all

Phase

Status

Completed 12 Recruiting 4 Withdrawn 3 Terminated 3 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cisplatin 447 Cyclophosphamide 311 Radiotherapy 310 Carboplatin 304 Paclitaxel 288 Capecitabine 279 Oxaliplatin 271 Docetaxel 269 Gemcitabine 266 Fluorouracil 240 apatinib 219 Drug Therapy 198 Bevacizumab 187 camrelizumab 181 Etoposide 175 Irinotecan 153 Doxorubicin 150 Dexamethasone 134 Leucovorin 131 Cytarabine 128 sintilimab 115 Pemetrexed 113 anlotinib 111 pembrolizumab 108 toripalimab 107 S 1 (combination) 105 Rituximab 105 Vincristine 103 Neoadjuvant Therapy 103 fludarabine 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05697510 2023-04-06

SILTUXILAM

Nantes University Hospital

Phase 1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡